Drug Profile
SPP 200 - Speedel
Latest Information Update: 23 Jan 2013
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer Speedel
- Class Anticoagulants; Cardiovascular therapies; Hirudins
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis